Profile
Sondra S.
Newman is currently the Global Head-Investor Relations at Repligen Corp.
Prior to this, she worked as the Director-Investor Relations at NitroMed, Inc.
Sondra S. Newman active positions
| Companies | Position | Start |
|---|---|---|
| REPLIGEN CORPORATION | Investor Relations Contact | - |
Former positions of Sondra S. Newman
| Companies | Position | End |
|---|---|---|
NitroMed, Inc.
 NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | Public Communications Contact | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| REPLIGEN CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
NitroMed, Inc.
NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | Health Technology |
- Stock Market
- Insiders
- Sondra S. Newman
